Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. (Q43724345)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Luisa Ricciardi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

F Purello-D'Ambrosio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R A Merendino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S Isola

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P Puccinelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S Parmiani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Allergy

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1295-1302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529901%20AND%20SRC:MED&resulttype=core&format=json

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Immunologic mechanisms of specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X

Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01027.X